Fig. 7

miR-96 inhibits the growth of CRC in vivo. a-c: Representative images of xenograft tumors (a) and quantitative analysis of tumor volume (b) and weight (c) after administration of miR-96 antagomir; d-e: Protein expression of FTO, MYC, CDK2, CDK4, Ki-67, PCNA, Bcl-2, AMPKα2 and Bax in tumor tissues of mice after administration of miR-96 antagomir measured by Western blot analysis. ^*p < 0.05. Measurement data (mean ± standard deviation) between the two groups were compared by unpaired t test and those among multiple groups at different time points were compared by repeated measures ANOVA with Bonferroni post hoc test. n = 6